Tel:4000-996-336 CN
Menu

genetron health

Strong scientific research ability

Genetron Health’s research service team consists of experts in cancer genomics, bioinformatics and project management with great experience in both basic and clinical cancer research. Internationally, Genetron Health has set up a R&D center in Research Triangle Park, North Carolina, U.S., developed long-term collaborations with Duke University and established a strategic partnership with Dr. Bert Vogelstein’s team at Johns Hopkins University. Domestically, Genetron Health has cultivated long-term and stable scientific collaborations with top hospitals in China and has published dozens of high impact research papers. The company will continue to provide first-class, customized research services.

genetron health

First-class hardware platforms

Genetron Health has partnered with Thermo Fisher to build a world-class laboratory for clinical research. The laboratory has the most advanced detection platform, comprehensive and diverse, can quickly and accurately according to clinical samples of various types of molecule detection, provide strong support for cancer genomics research and clinical application: two generation sequencing (NGS), generation sequencing (Sanger) and digital PCR (dPCR), fluorescence quantitative PCR (qPCR), pyrosequencing (Pyrose-quencing), fluorescence capillary electrophoresis, fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Equipment including Novoseq 6000,HiSeq X Ten,HiSeq 4000,MiSeq,NextSeq, QuantStudio,RainDance,PyroMark, etc.. The HiSeq X Ten sequencing system is currently the world's most cost-effective sequencing platform, with a capacity of sequencing 18,000 human whole genomes per year. With this capacity, Genetron Health can perform clinical tests covering whole genome sequencing, whole exome sequencing, RNA-seq, and liquid biopsies rapidly and accurately, providing a one-stop solution for cancer genomic studies.

genetron health

High-performance computing platform

Genetron Health has a high-performance computing center with proprietary software for data analysis. We have also established an exclusive strategic partnership with Personal Genomic Diagnostics (PGDx), a genetic testing company founded by Professor Bert Vogelstein of John Hopkins University, with a jointly developed cutting-edge technology platform for analyzing sequencing data.Our high-performance computing platform can store, process and analyze large-scale genomics data. Genetron Health maintains several cancer genome databases synchronized with the international database, with updated information on cancer genomic discoveries and therapeutic targets. These capabilities ensure excellent analysis services for our partners.

genetron health

High-quality scientific research achievements

Genetron Health's research team has more than 20 years of experience in cancer genomics research and clinical and translational research. The team includes professors and scholars from world-class universities, experts from the Recruitment Program of Global Experts, who had been keeping an extensive and in-depth cooperation with cancer research clinicians, experts and scholars in scientific research. Up to now, Genetron Health's scientific research team has completed several large research projects in cooperation with our partners, and has produced dozens of research papers (Science, Nature, New England Journal of Medicine), which are rather influential in the industry. The strong scientific research and development capability and efficient clinical and translational capability of Genetron Health, have been highly recognized in the industry.

genetron health

Case of Cooperation

Internationally, Genetron Health has set up a R&D center in Research Triangle Park, North Carolina, U.S., developed long-term collaborations with Duke University and established a strategic partnership with Dr. Bert Vogelstein’s team at Johns Hopkins University. Domestically, Genetron Health has cultivated long-term and stable scientific collaborations with top hospitals in China including Beijing Tiantan Hospital, the Chinese Academy of Medical Sciences Cancer Institute and Hospital, Shanghai Huashan Hospital, the Tumor hospital of Beijing University, Fudan University, and Zhejiang People's Hospital. These collaborations cover a wide range of cancers including brain cancer, lung cancer, gastric cancer, esophageal cancer, colorectal cancer, liver cancer, breast cancer and thyroid cancer.